International Randomized Study to Evaluate the Addition of Docetaxel (Taxotere) to the Combination of Cisplatin-5-Fluorouracil (TCF) vs. Cisplatin-5-Fluorouracil (CF) in the Induction Treatment of Nasopharyngeal Carcinoma (NPC) in Children and Adolescents
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2018
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 27 Jan 2012 Actual end date ( Jan 2012) added as reported by ClinicalTrials.gov.
- 27 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.